Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease - Trial NCT06002581
Access comprehensive clinical trial information for NCT06002581 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine and is currently Not yet recruiting. The study focuses on Parkinson's Disease. Target enrollment is 56 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Timeline & Enrollment
N/A
Aug 29, 2023
Jul 28, 2026
Primary Outcome
Change of Motor Function in PD by Low Frequency rTMS Stimulation
Summary
At present, no drug therapy has been proven to delay the progression of Parkinson's disease
 (PD). rTMS, as a non-invasive neuromodulation method, can regulate Slow-wave sleep (SWS). SWS
 is recognized closely related to neurodegeneration. However, there has been no clinical
 studies on if rTMS could delay the progression of PD by regulating SWS.
 
 The main purpose of this study is to explore the changes of SWS in non-rapid eye movement
 (NREM) sleep period in PD patients by using rTMS, and the relationship with potential
 improvements of SWS and motor symptom delay. The study aims to find a potential new treatment
 strategy to delay the neurodegenerative process in PD patients by modulating SWS by rTMS.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06002581
Device Trial